Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed in the record history.
    Difference
    0.1%
    Check dated 2026-03-11T14:11:52.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The history shows an added Revision: v3.4.2 and deletions of a funding notice and Revision: v3.4.1; these are administrative site maintenance changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T09:29:30.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:18:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes a 'Show glossary' option and notes explaining the color-coded changes (green and red highlights). The revision metadata was updated to v3.4.0 and the No FEAR Act data item was removed.
    Difference
    0.6%
    Check dated 2026-01-28T04:25:34.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 to the history and removed Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:11:29.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a new site revision entry, Revision: v3.3.3, to the history and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T09:09:22.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.